Arteris (NASDAQ:AIP) CEO K Charles Janac Sells 40,000 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $16.46, for a total value of $658,400.00. Following the completion of the sale, the chief executive officer directly owned 9,599,071 shares of the company’s stock, valued at $158,000,708.66. This trade represents a 0.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

K Charles Janac also recently made the following trade(s):

  • On Wednesday, December 3rd, K Charles Janac sold 2,058 shares of Arteris stock. The stock was sold at an average price of $15.52, for a total value of $31,940.16.
  • On Tuesday, December 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The shares were sold at an average price of $14.82, for a total transaction of $18,465.72.
  • On Wednesday, October 8th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.07, for a total transaction of $653,500.00.
  • On Monday, October 6th, K Charles Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $13.10, for a total transaction of $1,310,000.00.
  • On Monday, October 6th, K Charles Janac sold 5,755 shares of Arteris stock. The shares were sold at an average price of $14.00, for a total transaction of $80,570.00.
  • On Friday, October 3rd, K Charles Janac sold 11,821 shares of Arteris stock. The stock was sold at an average price of $11.07, for a total transaction of $130,858.47.
  • On Thursday, October 2nd, K Charles Janac sold 7,147 shares of Arteris stock. The shares were sold at an average price of $10.92, for a total transaction of $78,045.24.

Arteris Stock Up 3.6%

AIP stock traded up $0.63 during mid-day trading on Monday, reaching $18.18. 917,842 shares of the company traded hands, compared to its average volume of 588,102. The firm’s 50 day moving average price is $13.59 and its 200 day moving average price is $10.69. The stock has a market cap of $794.18 million, a price-to-earnings ratio of -21.90 and a beta of 1.49. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $18.21.

Arteris (NASDAQ:AIPGet Free Report) last posted its earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.25%.The company had revenue of $17.41 million for the quarter, compared to analyst estimates of $17.00 million. On average, analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Institutional Investors Weigh In On Arteris

Several large investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in Arteris during the second quarter valued at about $32,000. BNP Paribas Financial Markets raised its position in shares of Arteris by 75.0% in the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares during the period. Savant Capital LLC purchased a new stake in shares of Arteris during the 2nd quarter valued at approximately $97,000. Kapitalo Investimentos Ltda bought a new position in Arteris in the 2nd quarter worth approximately $104,000. Finally, Strs Ohio purchased a new position in Arteris in the 1st quarter valued at approximately $104,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on AIP shares. Cowen reaffirmed a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Jefferies Financial Group upgraded Arteris to a “hold” rating in a research note on Tuesday, October 28th. Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a research report on Monday, September 15th. TD Cowen boosted their price objective on Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Rosenblatt Securities upped their price objective on Arteris from $14.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Arteris presently has a consensus rating of “Moderate Buy” and an average target price of $17.50.

View Our Latest Analysis on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.